The myriad ways digital tools could change everything for pharma and the NHS
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Feat.: Making health apps a reality; Brexit and the supply chain; Patiet-centric sales
Why medical affairs is the most important role in the future of pharma
Biosimilars may have proven their worth, but how can adoption be sped up?
Pharma comms is one of the most dynamic sectors of the industry. So, what should be on communicators’ radar?
The National Institute for Health and Care Excellence has released new draft guidelines calling for faster treatment of patients with kidney stones experiencing severe pain.
18th July 2018
The number of people taking part in NHS clinical research studies sponsored by the life sciences industry has risen dramatically over the last year, show new figures by the National Institute for Health Research (NIHR).
18th July 2018
Janssen’s Symtuza has been approved US regulators as the first and only complete, darunavir-based single-tablet regimen for the treatment of HIV in adults.
18th July 2018
MPs have voted 305-301 that the UK should negotiate to remain part of the European Medicines Agency following Brexit.
18th July 2018
Vertex Pharmaceuticals is considering a final offer from NHS England on funding for its cystic fibrosis therapies, but said it remains concerned that the deal on the table does not fully reflect the value of its existing and future medicines for the condition.
18th July 2018
How AR, VR and gamification technology is being integrated with AI apps to enhance health outcomes
Colin Newbould, director of regulatory affairs and QP services at The Wasdell Group, on what the worst and best case Brexit scenarios could be mean for contract services and the wider pharma industry
How data trends in the financial services sector could transform pharma
A new report looks into how medtech must address key problems
Katie Ruane was just 22 when diagnosed with CML, and while drugs keep the disease in remission it still takes a huge toll on her life
NHS England’s assurance process provides a window of opportunity for pharma – but communication and joint working with the health service is key
The failure of several Alzheimer’s drug trials in the past year has dampened, but not destroyed, hopes for a cure
Home DNA tests are now common, but using genome sequencing to personalise drugs still has some way to go
The regulatory impacts of Brexit could be far-reaching, so now is not the time to take a ‘wait and see’ approach
The myriad ways digital tools could change everything for pharma and the NHS
Our Mobile Health is on a mission to build confidence in digital health by assessing and curating high-quality health apps. CEO Julie Bretland tells us what the company looks for in a good app and how digital health can change the industry
Patient-centred healthcare is here to stay, so how can pharma sales embrace it?
Why patient centricity throughout the lifecycle is not a fad, sales tactic or trend
Simon Grime, director of Fendix, explains how pharma can utilise its wealth of existing resources and content to improve collaboration with the NHS online
Peter Cherry, PhD, Medmeme’s vice president, information systems, explores how pharma can identify predatory journals and conferences
The importance of a patient-centric focus to improve the real-world use of medicine was extensively discussed during the 3rd Annual Patient Engagement and Experience Conference (16–17th May 2018, Amsterdam, Netherlands).
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
